2,3-bis(3'-hydroxybenzyl)butyrolactone has been researched along with Animal Mammary Carcinoma in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bowers, LW; Camp, KK; Fabian, CJ; Ford, NA; Hursting, SD; Kimler, BK; Lineberger, CG; Punjala, A; Rossi, EL | 1 |
Ammälä, J; Collan, YU; Eckerman, C; Huovinen, R; Lehtilä, R; Mäkelä, SI; Saarinen, NM; Santti, RS; Sjöholm, R; Valentín-Blasini, L; Wärri, A | 1 |
Chen, JM; Power, KA; Saarinen, NM; Thompson, LU; Ward, WE | 1 |
Airio, M; Mäkelä, S; Saarinen, NM; Smeds, A; Wärri, A | 1 |
1 review(s) available for 2,3-bis(3'-hydroxybenzyl)butyrolactone and Animal Mammary Carcinoma
Article | Year |
---|---|
Role of dietary lignans in the reduction of breast cancer risk.
Topics: 4-Butyrolactone; Animals; Anticarcinogenic Agents; Bacteria; Breast Neoplasms; Cell Division; Diet; Female; Humans; Intestines; Lignans; Mammary Neoplasms, Animal; Plants, Edible; Risk Factors | 2007 |
3 other study(ies) available for 2,3-bis(3'-hydroxybenzyl)butyrolactone and Animal Mammary Carcinoma
Article | Year |
---|---|
The flaxseed lignan secoisolariciresinol diglucoside decreases local inflammation, suppresses NFκB signaling, and inhibits mammary tumor growth.
Topics: 4-Butyrolactone; Animals; Anti-Inflammatory Agents; Biomarkers; Butylene Glycols; Cell Line, Tumor; Cell Survival; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Flax; Gene Expression Profiling; Glucosides; Immunohistochemistry; Lignans; Mammary Neoplasms, Animal; Mice; NF-kappa B; Signal Transduction | 2019 |
Enterolactone inhibits the growth of 7,12-dimethylbenz(a)anthracene-induced mammary carcinomas in the rat.
Topics: 4-Butyrolactone; 9,10-Dimethyl-1,2-benzanthracene; Animals; Aromatase Inhibitors; Carcinogens; Cell Division; Enzyme Inhibitors; Estrogens; Estrogens, Non-Steroidal; Female; Isoflavones; Lignans; Mammary Neoplasms, Animal; Models, Chemical; Organ Size; Phytoestrogens; Plant Preparations; Rats; Rats, Sprague-Dawley; Time Factors; Uterus | 2002 |
Genistein alone and in combination with the mammalian lignans enterolactone and enterodiol induce estrogenic effects on bone and uterus in a postmenopausal breast cancer mouse model.
Topics: 4-Butyrolactone; Animals; Antineoplastic Agents; Bone and Bones; Bone Density; Drug Combinations; Estrogens; Female; Genistein; Humans; Lignans; Mammary Neoplasms, Animal; Mice; Mice, Inbred BALB C; Mice, Nude; Organ Size; Ovariectomy; Phytoestrogens; Postmenopause; Uterus; Xenograft Model Antitumor Assays | 2006 |